CN Stock MarketDetailed Quotes
688302 Hinova Pharmaceuticals Inc.
- 30.22
- +0.23+0.77%
Market Closed Dec 27 15:00 CST
2.99BMarket Cap-14.23P/E (TTM)
30.85High29.81Low8.60KlotVolume30.04Open29.99Pre Close26.13MTurnover1.18%Turnover RatioLossP/E (Static)99.02MShares53.2852wk High2.43P/B2.20BFloat Cap22.6052wk Low35.99Limit Up72.72MShs Float78.77Historical High23.99Limit Down3.47%Amplitude22.60Historical Low--Dividend TTM30.39Avg Price3.64KlotAsk--Div YieldTTM100Lot Size4.35KlotBid
Hinova Pharmaceuticals Inc. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -33.92%488.05M | -31.67%533.44M | -64.16%283.46M | -32.32%813.23M | 167.97%738.54M | -43.78%780.7M | -2.54%790.8M | 33.33%1.2B | --275.61M | 31.08%1.39B |
| Transactional financial assets | -10.44%421.24M | -14.75%440.94M | 5.76%736.29M | -20.65%290.62M | -66.91%470.37M | 47.14%517.26M | --696.2M | --366.24M | --1.42B | --351.55M |
| Other receivables (including interest and dividends) | -10.22%1.29M | -36.82%895.04K | -43.71%969.59K | -17.10%1.39M | -19.26%1.44M | -17.21%1.42M | 134.25%1.72M | 207.53%1.67M | --1.78M | 645.98%1.71M |
| -Other receivable | ---- | -36.82%895.04K | ---- | -17.10%1.39M | ---- | -17.21%1.42M | ---- | 207.53%1.67M | ---- | 645.98%1.71M |
| Advance payment | -51.23%18.27M | -17.41%23.81M | 21.25%33.54M | 21.67%30.05M | 127.64%37.46M | 9.79%28.83M | -4.56%27.67M | -20.20%24.7M | --16.45M | -8.88%26.26M |
| Inventories | 3,647.95%165.21K | 3,087.82%146.95K | 25.97%5.17K | -13.94%5.58K | -15.97%4.41K | 15.79%4.61K | -22.13%4.1K | 31.82%6.48K | --5.25K | -20.57%3.98K |
| Other current assets | 54.33%27.75M | 65.65%23.76M | -15.70%17.08M | -30.13%11.93M | 9.03%17.98M | 0.77%14.35M | -23.71%20.26M | -24.16%17.08M | --16.49M | 38.61%14.24M |
| Total current assets | -24.41%956.76M | -23.80%1.02B | -30.28%1.07B | -28.80%1.15B | -26.91%1.27B | -24.68%1.34B | 77.10%1.54B | 68.68%1.61B | --1.73B | 62.23%1.78B |
| Non Current assets | ||||||||||
| Other non-current financial assets | 40.65%7.03M | 40.65%7.03M | 40.65%7.03M | 40.65%7.03M | --5M | --5M | --5M | --5M | ---- | ---- |
| Fixed assets | ---- | -23.28%5.01M | ---- | -16.62%5.84M | ---- | 2.79%6.53M | ---- | 35.41%7.01M | ---- | 30.39%6.35M |
| Fixed assets liquidation | ---- | ---- | ---- | --1.03K | ---- | --709.74 | ---- | ---- | ---- | ---- |
| Constru in process | ---- | 124.62%263.78M | ---- | 129.86%169.54M | ---- | 1,574.04%117.43M | ---- | 2,361.02%73.76M | ---- | 322.46%7.01M |
| Intangible assets | -2.07%30.72M | -2.06%30.89M | -2.05%31.05M | -2.04%31.21M | -2.03%31.37M | -2.02%31.53M | -2.17%31.7M | --31.86M | --32.02M | --32.18M |
| Long deferred expense | -80.00%10.31K | -66.67%20.62K | -57.14%30.92K | -50.00%41.23K | -44.44%51.54K | -40.00%61.85K | -36.36%72.16K | --82.46K | --92.77K | -67.72%103.08K |
| Usufruct assets | -29.23%9.67M | -27.77%10.63M | -26.52%11.58M | 115.56%12.61M | 101.08%13.66M | 106.91%14.71M | 98.02%15.77M | 28.72%5.85M | --6.79M | 119.96%7.11M |
| Other non current assets | -7.84%107.72M | -5.86%104.84M | 56,787.75%109.27M | 56,508.54%118.07M | 18,371.52%116.89M | 14,478.24%111.37M | -87.14%192.08K | -98.55%208.56K | --632.81K | 26.63%763.93K |
| Total non current assets | 44.54%447.98M | 47.29%422.19M | 136.38%363.09M | 178.22%344.34M | 356.33%309.94M | 435.51%286.64M | 201.91%153.6M | 356.57%123.76M | --67.92M | 400.91%53.53M |
| Total assets | -10.85%1.4B | -11.29%1.45B | -15.13%1.43B | -14.03%1.49B | -12.45%1.58B | -11.26%1.63B | 84.01%1.69B | 76.62%1.74B | --1.8B | 65.49%1.84B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | ---- | ---- | ---- | --30M | --30M | --30M | --30M | ---- | ---- |
| Notes payable and accounts payable | 25.41%134.28M | 22.65%126.59M | -20.60%77.6M | 3.23%92.87M | 41.39%107.07M | 60.67%103.21M | 20.79%97.73M | 8.34%89.96M | --75.73M | -9.93%64.24M |
| -Notes payable | --49.08M | --36.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts payable | -20.42%85.2M | -12.81%89.98M | -20.60%77.6M | 3.23%92.87M | 41.39%107.07M | 60.67%103.21M | 20.79%97.73M | 8.34%89.96M | --75.73M | -9.93%64.24M |
| Contract liabilities | --212.6K | --164.6K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | -4.81%7.02M | -33.81%6.45M | -46.72%3.2M | -45.56%4.96M | -19.47%7.38M | 100.92%9.74M | 171.71%6M | 5.14%9.12M | --9.16M | 164.56%4.85M |
| Taxs payable | 10.75%1.2M | 273.81%1.07M | 1,651.34%978.77K | 54.77%1.22M | 2,098.01%1.09M | -58.52%286.57K | -83.32%55.89K | 1,199.51%785.1K | --49.43K | 281.23%690.88K |
| Other payable (including interest and dividends) | -6.45%3.96M | -5.82%4.02M | 28.18%5.05M | -32.42%4.03M | -27.51%4.23M | -16.07%4.27M | -25.26%3.94M | 2.14%5.96M | --5.84M | -12.28%5.09M |
| -Other payable | ---- | -5.82%4.02M | ---- | -32.42%4.03M | ---- | -16.07%4.27M | ---- | 2.14%5.96M | ---- | -12.28%5.09M |
| Non current liabilities due within one year | -18.16%3.38M | -17.16%3.57M | -8.68%3.76M | 54.06%3.77M | -93.94%4.13M | -93.61%4.31M | -95.67%4.12M | -97.39%2.45M | --68.11M | 4,155.16%67.44M |
| Total current liabilities | -2.49%150.05M | -6.56%141.86M | -36.14%90.58M | -22.73%106.84M | -3.14%153.89M | 6.68%151.82M | -22.86%141.84M | -27.73%138.27M | --158.88M | -34.73%142.3M |
| Current liabilities | ||||||||||
| Long term deferred income | 104.32%16.55M | 104.32%16.55M | 5.56%8.55M | 5.56%8.55M | 1,990.32%8.1M | 1,308.70%8.1M | 839.13%8.1M | 604.35%8.1M | --387.5K | -68.06%575K |
| Lease liabilities | -31.63%6.57M | -25.65%7.64M | -17.52%9.21M | 174.22%9.08M | 160.91%9.6M | 161.02%10.28M | 170.86%11.17M | 198.25%3.31M | --3.68M | 225.50%3.94M |
| Total non current liabilities | 30.57%23.12M | 31.65%24.19M | -7.82%17.76M | 54.50%17.63M | 335.17%17.7M | 307.29%18.38M | 286.49%19.27M | 404.87%11.41M | --4.07M | 49.92%4.51M |
| Total liabilities | 0.92%173.17M | -2.43%166.05M | -32.75%108.34M | -16.84%124.47M | 5.30%171.59M | 15.92%170.19M | -14.70%161.11M | -22.68%149.68M | --162.95M | -33.58%146.82M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%99.02M | 0.00%99.02M | 0.00%99.02M | 0.00%99.02M | 0.00%99.02M | 0.00%99.02M | 33.34%99.02M | 33.34%99.02M | --99.02M | 33.34%99.02M |
| Capital reserve funds | 1.49%2.58B | 1.97%2.57B | 2.52%2.56B | 3.06%2.56B | 3.43%2.54B | 3.64%2.52B | 74.08%2.5B | 76.16%2.48B | --2.45B | 80.09%2.43B |
| Retained profit | -17.03%-1.44B | -19.75%-1.39B | -24.83%-1.34B | -29.53%-1.29B | -34.57%-1.23B | -37.85%-1.16B | -37.11%-1.07B | -43.41%-996.06M | ---917.07M | -57.04%-842.41M |
| Other composite income | -77.90%58.57K | -43.88%162.12K | 44.12%135.89K | -19.02%109.51K | 263.76%264.99K | 15.56%288.88K | 212.99%94.29K | 284.26%135.24K | --72.85K | 570.69%249.98K |
| Shareholders equity without minority interests | -12.29%1.23B | -12.33%1.28B | -13.28%1.33B | -13.77%1.37B | -14.21%1.4B | -13.63%1.46B | 109.55%1.53B | 101.00%1.59B | --1.64B | 90.14%1.69B |
| Total shareholder equity | -12.29%1.23B | -12.33%1.28B | -13.28%1.33B | -13.77%1.37B | -14.21%1.4B | -13.63%1.46B | 109.55%1.53B | 101.00%1.59B | --1.64B | 90.14%1.69B |
| Total liabilityies and equity | -10.85%1.4B | -11.29%1.45B | -15.13%1.43B | -14.03%1.49B | -12.45%1.58B | -11.26%1.63B | 84.01%1.69B | 76.62%1.74B | --1.8B | 65.49%1.84B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
